Glidewell Laboratories recently launched Newport Biologics, a line of regenerative materials.
The new line features allograft and alloplast bone graft options as well as resorbable barrier membranes and a collagen-based wound dressing, according to a press release.
The line was created to make it easier for clinicians to access high-quality regenerative materials to meet the growing demand for grafting procedures. Along with tooth loss and tissue resorption that results from periodontal defects, extraction sockets, and other bone deficiencies, an increasing percentage of dental implant procedures require bone grafting as well.
The allograft materials in the line are sourced from the University of Miami Tissue Bank and resorbable membranes are engineered to optimize handling characteristics to support the clinician's preferred bone grafting techniques. Individual product names clearly reflect the material's composition and usage.
View Full Press Release
Source: Glidewell Laboratories